Pleural Effusion in Lung Cancer: More Questions than Answers
Open Access
- 1 May 2012
- journal article
- review article
- Published by S. Karger AG in Respiration
- Vol. 83 (5), 367-376
- https://doi.org/10.1159/000338169
Abstract
Lung cancer remains the most common fatal malignancy, despite more aggressive therapies. Few patients will survive 5 years, as up to 80% of the patients will present with advanced-stage disease at diagnosis. Chemotherapy offers little benefit in terms of median survival and disease-free survival in patients with advanced-stage non-small-cell lung carcinoma (NSCLC). In the last decade, the development of new targeted therapies based on the better understanding of different paths of carcinogenesis has given new hope to both physicians and patients. Metastatic pleural effusion from lung cancer has a particularly poor prognosis, and in NSCLC it is actually reclassified as stage IV disease. A possible explanation of this observation is differences in the genomics between primary tumors and metastasis, leading to possible different therapeutic approaches with novel molecular therapies in this patient population. The current review aims to summarize the actual situation of research in pleural disease due to lung carcinoma in relation to novel targeted therapies tested in this patient population.Keywords
This publication has 69 references indexed in Scilit:
- Diagnostic molecular biomarkers for malignant pleural effusionsFuture Oncology, 2011
- Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patientBMC Research Notes, 2010
- Diagnostic Work-Up of Pleural EffusionsRespiration, 2008
- The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung CancerJournal of Thoracic Oncology, 2007
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Revisit of 1997 TNM Staging System—Survival Analysis of 1112 Lung Cancer Patients in TaiwanJapanese Journal of Clinical Oncology, 2006
- Epidermal growth factor regulates the expression of its own receptor.Proceedings of the National Academy of Sciences of the United States of America, 1985
- The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patientsCancer, 1985
- Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene.Proceedings of the National Academy of Sciences of the United States of America, 1985
- Isolated Pleural Effusion in Small Cell Lung Carcinoma: Favorable PrognosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1982